Event Description
Marburg virus disease (MVD) is a severe and often fatal hemorrhagic fever that is clinically similar to the Ebola virus disease. In fall 2024, Rwanda experienced the third-largest recorded MVD outbreak, with 66 reported cases and 15 deaths, the majority of which were among healthcare workers. In response, Rwanda’s Ministry of Health launched a comprehensive national program that included widespread public health awareness campaigns, promotion of hygiene practices, strict monitoring of transmissions, isolation of potential cases, effective treatment protocols for confirmed cases, and the distribution of investigational vaccines and therapeutics. The Ministry of Health declared the outbreak over by December 2024. Although there are currently no licensed vaccines or treatments for MVD, several candidate vaccines are in development, and some have entered clinical trials. Experts will share experiences and lessons learned from managing the MVD outbreak in Rwanda and the development of a candidate vaccine.
Event Information
Free and open to the public; registration required. For more information, please visit the event webpage. Please email [email protected] with any questions.
Hosted by ICAP at Columbia University.
